37.49
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agios Pharmaceuticals Inc | AGIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 37.49 | 0.00 | 0.00 | 0.00 | 37.49 | 04:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 28.00 | 54.90 | 26.90 | 49.0% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 37.49 | USD |
Agios Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.57B | 68.51M | $ -346.03M | -6.86 | - | 67.66M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Agios Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 35.58 | 38.435 | 34.08 | 36.00 | 747,791 | 1.91 | 5.37% |
| 1 Month | 43.68 | 46.71 | 27.774 | 35.92 | 756,961 | -6.19 | -14.17% |
| 3 Months | 48.12 | 54.6836 | 27.774 | 44.70 | 705,645 | -10.63 | -22.09% |
| 6 Months | 34.07 | 54.6836 | 27.774 | 40.96 | 789,514 | 3.42 | 10.04% |
| 1 Year | 68.09 | 69.64 | 27.774 | 42.86 | 670,703 | -30.60 | -44.94% |
| 3 Years | 53.81 | 99.8242 | 27.774 | 56.18 | 537,842 | -16.32 | -30.33% |
| 5 Years | 93.24 | 126.35 | 27.774 | 58.30 | 587,765 | -55.75 | -59.79% |
Agios Pharmaceuticals Description
| Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. |
